Recently, Dr. Xue-ru Wu and his associates have demonstrated that increased glycolysis by enolase-1 or pyruvate kinase 2 (PKM2) can promote tumorigenesis in mutant Ha-ras-driven urothelial carcinoma [26,27]. This evidence concerns the gene PKM and urothelial carcinoma.